Telomir Pharmaceuticals, Inc. Common Stock
$1.05
+0.00 (+0.00%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -6.2%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -16.0%
Own TELO?
See how TELO contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.